Cargando…
Evaluating the use of corticosteroids in preventing and treating bronchopulmonary dysplasia in preterm neonates
Approximately 15 million babies worldwide are born premature, and complications of prematurity are one of the leading causes of death in neonates. Neonatal respiratory distress syndrome (NRDS) and bronchopulmonary dysplasia (BPD) are two of the most common and serious consequences of prematurity. Sy...
Autores principales: | Olaloko, Oreoluwa, Mohammed, Raihan, Ojha, Utkarsh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037151/ https://www.ncbi.nlm.nih.gov/pubmed/30013381 http://dx.doi.org/10.2147/IJGM.S158184 |
Ejemplares similares
-
Corticosteroids for the prevention of bronchopulmonary dysplasia in preterm infants: a network meta-analysis
por: Zeng, Linan, et al.
Publicado: (2018) -
Use of inhaled corticosteroids for the prevention and/or treatment of bronchopulmonary dysplasia in preterm infants: a systematic review protocol
por: Shinwell, Eric S., et al.
Publicado: (2015) -
Bronchopulmonary dysplasia and neurodevelopmental outcome in extremely preterm neonates
por: Trittmann, J. K., et al.
Publicado: (2013) -
Role of Postnatal Corticosteroids in the Treatment or Prevention of Bronchopulmonary Dysplasia
por: Bulbul, Ali, et al.
Publicado: (2023) -
Systemic postnatal corticosteroid use for the prevention of bronchopulmonary dysplasia and its relationship to early neurodevelopment in extremely preterm infants
por: Esterman, Emilia, et al.
Publicado: (2023)